1,1-dichloroethene increases expression ISO RGD:1317754 6480464 vinylidene chloride results in increased expression of SGO1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1317754 6480464 1, 2-Dimethylhydrazine results in increased expression of SGO1 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:1317754 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:29627306 17alpha-ethynylestradiol affects expression ISO RGD:1317754 6480464 Ethinyl Estradiol affects the expression of SGO1 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RGD:1344948 6480464 Estradiol results in increased expression of SGO1 mRNA CTD PMID:19167446 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SGO1 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:1317754 6480464 Estradiol results in increased expression of SGO1 mRNA CTD PMID:25210133 17beta-estradiol multiple interactions ISO RGD:1317754 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of SGO1 mRNA] CTD PMID:25210133 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SGO1 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:1344948 6480464 2 more ... CTD PMID:23146750 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1317754 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1344948 6480464 2 more ... CTD PMID:23146750 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1317754 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1344948 6480464 Tetrachlorodibenzodioxin results in decreased expression of SGO1 mRNA CTD PMID:21802500 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SGO1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317754 6480464 Tetrachlorodibenzodioxin affects the expression of SGO1 mRNA CTD PMID:21570461 2-butoxyethanol increases expression ISO RGD:1317754 6480464 n-butoxyethanol results in increased expression of SGO1 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:1344948 6480464 beta-methylcholine affects the expression of SGO1 mRNA CTD PMID:21179406 3-methylcholanthrene increases expression ISO RGD:1317754 6480464 Methylcholanthrene results in increased expression of SGO1 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SGO1 mRNA CTD PMID:36041667 4-hydroxynon-2-enal decreases expression ISO RGD:1317754 6480464 4-hydroxy-2-nonenal results in decreased expression of SGO1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1317754 6480464 Fenretinide results in increased expression of SGO1 mRNA CTD PMID:28973697 acrylamide decreases expression ISO RGD:1344948 6480464 Acrylamide results in decreased expression of SGO1 mRNA CTD PMID:32763439 all-trans-retinoic acid decreases expression ISO RGD:1344948 6480464 Tretinoin results in decreased expression of SGO1 mRNA CTD PMID:33167477 benzo[a]pyrene decreases expression ISO RGD:1344948 6480464 Benzo(a)pyrene results in decreased expression of SGO1 mRNA CTD PMID:21802500 benzo[a]pyrene increases expression ISO RGD:1317754 6480464 Benzo(a)pyrene results in increased expression of SGO1 mRNA CTD PMID:20504355 more ... benzo[b]fluoranthene increases expression ISO RGD:1317754 6480464 benzo(b)fluoranthene results in increased expression of SGO1 mRNA CTD PMID:26377693 bisphenol A increases expression ISO RGD:1344948 6480464 bisphenol A results in increased expression of SGO1 mRNA CTD PMID:23146750 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SGO1 mRNA CTD PMID:36041667 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SGO1 mRNA CTD PMID:32145629 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SGO1 mRNA CTD PMID:36041667 calcitriol multiple interactions ISO RGD:1344948 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SGO1 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1344948 6480464 Calcitriol results in decreased expression of SGO1 mRNA CTD PMID:21592394 carbon nanotube affects expression ISO RGD:1317754 6480464 Nanotubes, Carbon affects the expression of SGO1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1317754 6480464 Nanotubes, Carbon analog results in increased expression of SGO1 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1344948 6480464 CGP 52608 promotes the reaction [RORA protein binds to SGO1 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1317754 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SGO1 mRNA CTD PMID:20938992 clofibrate multiple interactions ISO RGD:1317754 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SGO1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SGO1 mRNA] CTD PMID:17585979 coumestrol multiple interactions ISO RGD:1344948 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1344948 6480464 Coumestrol results in increased expression of SGO1 mRNA CTD PMID:19167446 dibenz[a,h]anthracene increases expression ISO RGD:1317754 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:1317754 6480464 Dibutyl Phthalate results in decreased expression of SGO1 mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1344948 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGO1 mRNA CTD PMID:27188386 Enterolactone multiple interactions ISO RGD:1344948 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO1 mRNA CTD PMID:19167446 ethyl methanesulfonate increases expression ISO RGD:1344948 6480464 Ethyl Methanesulfonate results in increased expression of SGO1 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:1317754 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SGO1 mRNA CTD PMID:20938992 L-methionine multiple interactions ISO RGD:1317754 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SGO1 mRNA CTD PMID:20938992 lucanthone decreases expression ISO RGD:1344948 6480464 Lucanthone results in decreased expression of SGO1 mRNA CTD PMID:21148553 methyl methanesulfonate increases expression ISO RGD:1344948 6480464 Methyl Methanesulfonate results in increased expression of SGO1 mRNA CTD PMID:23649840 N-Nitrosopyrrolidine decreases expression ISO RGD:1344948 6480464 N-Nitrosopyrrolidine results in decreased expression of SGO1 mRNA CTD PMID:32234424 ozone multiple interactions ISO RGD:1317754 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SGO1 mRNA more ... CTD PMID:25658374 , PMID:34911549 ozone increases expression ISO RGD:1317754 6480464 Ozone results in increased expression of SGO1 mRNA CTD PMID:25658374 , PMID:31626304 paracetamol increases expression ISO RGD:1344948 6480464 Acetaminophen results in increased expression of SGO1 mRNA CTD PMID:22230336 paracetamol multiple interactions ISO RGD:1317754 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SGO1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SGO1 mRNA] CTD PMID:17585979 paraquat decreases expression ISO RGD:1317754 6480464 Paraquat results in decreased expression of SGO1 mRNA CTD PMID:29627306 PCB138 multiple interactions ISO RGD:1317754 6480464 [2 more ... CTD PMID:25510870 perfluorooctanoic acid increases expression ISO RGD:1344948 6480464 perfluorooctanoic acid results in increased expression of SGO1 mRNA CTD PMID:23146750 phenobarbital increases expression ISO RGD:1317754 6480464 Phenobarbital results in increased expression of SGO1 mRNA CTD PMID:19482888 phenobarbital affects expression ISO RGD:1317754 6480464 Phenobarbital affects the expression of SGO1 mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO RGD:1317754 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SGO1 mRNA] CTD PMID:19482888 phenylmercury acetate decreases expression ISO RGD:1344948 6480464 Phenylmercuric Acetate results in decreased expression of SGO1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1344948 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGO1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1344948 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SGO1 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:1317754 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of SGO1 mRNA] CTD PMID:17950772 pirinixic acid increases expression ISO RGD:1317754 6480464 pirinixic acid results in increased expression of SGO1 mRNA CTD PMID:17950772 , PMID:23811191 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1317754 6480464 Pregnenolone Carbonitrile results in increased expression of SGO1 mRNA CTD PMID:22698814 propanal decreases expression ISO RGD:1344948 6480464 propionaldehyde results in decreased expression of SGO1 mRNA CTD PMID:26079696 resveratrol multiple interactions ISO RGD:1344948 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SGO1 mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:1344948 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGO1 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1344948 6480464 Silicon Dioxide analog results in increased expression of SGO1 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1317754 6480464 Silicon Dioxide results in increased expression of SGO1 mRNA CTD PMID:29341224 sodium arsenite decreases expression ISO RGD:1317754 6480464 sodium arsenite results in decreased expression of SGO1 mRNA CTD PMID:17998272 sodium arsenite affects expression ISO RGD:1344948 6480464 sodium arsenite affects the expression of SGO1 mRNA CTD PMID:29301061 sunitinib decreases expression ISO RGD:1344948 6480464 Sunitinib results in decreased expression of SGO1 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression ISO RGD:1317754 6480464 Tacrolimus results in increased expression of SGO1 mRNA CTD PMID:29362864 tamoxifen affects expression ISO RGD:1317754 6480464 Tamoxifen affects the expression of SGO1 mRNA CTD PMID:17555576 testosterone multiple interactions ISO RGD:1344948 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SGO1 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SGO1 mRNA CTD PMID:32741896 testosterone decreases expression ISO RGD:1344948 6480464 Testosterone results in decreased expression of SGO1 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1317754 6480464 Carbon Tetrachloride affects the expression of SGO1 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SGO1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1317754 6480464 titanium dioxide results in increased expression of SGO1 mRNA CTD PMID:23557971 trichloroethene increases expression ISO RGD:1317754 6480464 Trichloroethylene results in increased expression of SGO1 mRNA CTD PMID:25549359 trimellitic anhydride increases expression ISO RGD:1317754 6480464 trimellitic anhydride results in increased expression of SGO1 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1344948 6480464 troglitazone results in decreased expression of SGO1 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO RGD:1317754 6480464 trovafloxacin results in decreased expression of SGO1 mRNA CTD PMID:35537566 valproic acid decreases expression ISO RGD:1344948 6480464 Valproic Acid results in decreased expression of SGO1 mRNA CTD PMID:28001369 zaragozic acid A decreases expression ISO RGD:1317754 6480464 squalestatin 1 results in decreased expression of SGO1 mRNA CTD PMID:27225895 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of SGO1 mRNA CTD PMID:27225895